Covered recipient · General Payments record
KAREN J WEST
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$711.76
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $304.05 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $38.93 | 2 |
| Lundbeck LLC | $36.62 | 2 |
| Organon LLC | $31.63 | 1 |
| SK Life Science, Inc. | $31.33 | 2 |
| Exeltis, USA Inc. | $30.70 | 2 |
| Kyowa Kirin, Inc. | $22.62 | 1 |
| UCB, Inc. | $21.59 | 1 |
| EMD Serono, Inc. | $20.94 | 1 |
| Lilly USA, LLC | $19.72 | 1 |
| Abbott Laboratories | $18.86 | 1 |
| LivaNova USA, Inc. | $17.90 | 1 |
| ARGENX US, INC. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.86 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125052527 | CMS |
| ARGENX US, INC. | $13.21 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142144037 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.47 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086310857 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.46 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086304005 | CMS |
| EMD Serono, Inc. | $20.94 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120230460 | CMS |
| Exeltis, USA Inc. | $13.61 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021381 | CMS |
| Exeltis, USA Inc. | $17.09 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021383 | CMS |
| Kyowa Kirin, Inc. | $22.62 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127051695 | CMS |
| Lilly USA, LLC | $19.72 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135722085 | CMS |
| LivaNova USA, Inc. | $17.90 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790493 | CMS |
| Lundbeck LLC | $15.78 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146105911 | CMS |
| Lundbeck LLC | $20.84 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146105913 | CMS |
| Organon Llc | $31.63 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136284204 | CMS |
| SK Life Science, Inc. | $17.52 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154133233 | CMS |
| SK Life Science, Inc. | $13.81 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154133261 | CMS |
| UCB, Inc. | $21.59 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143448031 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.